Literature DB >> 18577756

Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?

Steven R Houser1, Jeffery D Molkentin.   

Abstract

In noncontractile cells, a sustained increase in total cytoplasmic Ca(2+) concentration is typically needed to activate the intracellular protein phosphatase calcineurin, leading to dephosphorylation of the transcription factor nuclear factor of activated T cells (NFAT), its nuclear translocation, and induction of gene expression. It remains a mystery exactly how Ca(2+)-dependent signaling pathways, such as that mediated by calcineurin-NFAT, are regulated in contracting cardiac myocytes given the highly specialized manner in which Ca(2+) concentration rhythmically cycles in excitation-contraction coupling. Here, we critically review evidence that supports the hypothesis that calcineurin-NFAT signaling is regulated by contractile Ca(2+) transients in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577756      PMCID: PMC2680250          DOI: 10.1126/scisignal.125pe31

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  30 in total

Review 1.  Calcium signaling in cardiac ventricular myocytes.

Authors:  Donald M Bers; Tao Guo
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

2.  Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers.

Authors:  Tiansheng Shen; Yewei Liu; Zoltán Cseresnyés; Arie Hawkins; William R Randall; Martin F Schneider
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

Review 3.  Calcium and cardiomyopathies.

Authors:  E G Kranias; D M Bers
Journal:  Subcell Biochem       Date:  2007

4.  Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation.

Authors:  Chih-Chung Lin; Jiunn-Lee Lin; Chich-Sheng Lin; Mei-Chuan Tsai; Ming-Jai Su; Ling-Ping Lai; Shoei K Stephen Huang
Journal:  Chest       Date:  2004-12       Impact factor: 9.410

5.  Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.

Authors:  Carsten Zobel; Zameneh Kassiri; The-Tin T Nguyen; Yang Meng; Peter H Backx
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

6.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

7.  Modulation of action potential duration on myocyte hypertrophic pathways.

Authors:  Djamel Lebeche; Roger Kaprielian; Roger Hajjar
Journal:  J Mol Cell Cardiol       Date:  2006-05       Impact factor: 5.000

8.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

9.  Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.

Authors:  Hiroyuki Nakayama; Xiongwen Chen; Christopher P Baines; Raisa Klevitsky; Xiaoying Zhang; Hongyu Zhang; Naser Jaleel; Balvin H L Chua; Timothy E Hewett; Jeffrey Robbins; Steven R Houser; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells.

Authors:  Juan Antonio Valdés; Eduardo Gaggero; Jorge Hidalgo; Nancy Leal; Enrique Jaimovich; M Angélica Carrasco
Journal:  Am J Physiol Cell Physiol       Date:  2008-01-09       Impact factor: 4.249

View more
  46 in total

1.  Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptation.

Authors:  Christopher E Wall; Steven Cozza; Cecilia A Riquelme; W Richard McCombie; Joseph K Heimiller; Thomas G Marr; Leslie A Leinwand
Journal:  Physiol Genomics       Date:  2010-11-02       Impact factor: 3.107

2.  E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator.

Authors:  Ang Guo; Yihui Wang; Biyi Chen; Yunhao Wang; Jinxiang Yuan; Liyang Zhang; Duane Hall; Jennifer Wu; Yun Shi; Qi Zhu; Cheng Chen; William H Thiel; Xin Zhan; Robert M Weiss; Fenghuang Zhan; Catherine A Musselman; Miles Pufall; Weizhong Zhu; Kin Fai Au; Jiang Hong; Mark E Anderson; Chad E Grueter; Long-Sheng Song
Journal:  Science       Date:  2018-11-08       Impact factor: 47.728

3.  Location and function of transient receptor potential canonical channel 1 in ventricular myocytes.

Authors:  Qinghua Hu; Azmi A Ahmad; Thomas Seidel; Chris Hunter; Molly Streiff; Linda Nikolova; Kenneth W Spitzer; Frank B Sachse
Journal:  J Mol Cell Cardiol       Date:  2020-01-23       Impact factor: 5.000

4.  TRPC channels are necessary mediators of pathologic cardiac hypertrophy.

Authors:  Xu Wu; Petra Eder; Baojun Chang; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 5.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

6.  Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.

Authors:  Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

7.  Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.

Authors:  Yijun Tang; Xixi Tian; Ruiwu Wang; Michael Fill; S R Wayne Chen
Journal:  Circ Res       Date:  2012-02-28       Impact factor: 17.367

8.  Altered calsequestrin glycan processing is common to diverse models of canine heart failure.

Authors:  Sony Jacob; Naama H Sleiman; Stephanie Kern; Larry R Jones; Javier A Sala-Mercado; Timothy P McFarland; Hani H Sabbah; Steven E Cala
Journal:  Mol Cell Biochem       Date:  2013-03-01       Impact factor: 3.396

9.  TFAM overexpression reduces pathological cardiac remodeling.

Authors:  George H Kunkel; Christopher J Kunkel; Hazel Ozuna; Irina Miralda; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2018-10-23       Impact factor: 3.396

Review 10.  Cardiac hypertrophy and thyroid hormone signaling.

Authors:  Wolfgang Dillmann
Journal:  Heart Fail Rev       Date:  2009-01-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.